sq-11725 has been researched along with Growth Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, RE; Marx, C; Stark, AR | 1 |
1 other study(ies) available for sq-11725 and Growth Disorders
| Article | Year |
|---|---|
Neonatal effects of maternal nadolol therapy.
Topics: Female; Fetal Distress; Growth Disorders; Humans; Hypertension; Hypoglycemia; Infant, Newborn; Male; Nadolol; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Propanolamines | 1985 |